Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments.

Scorsetti M;Alongi F;Fogliata A;Pentimalli S;Navarria P;Lobefalo F;Garcia-Etienne C;Clivio A;Cozzi L;Mancosu P;Nicolini G;Vanetti E;Eboli M;Rossetti C;Rubino A;Sagona A;Arcangeli S;Gatzemeier W;Masci G;Torrisi R;Testori A;Alloisio M;Santoro A;Tinterri C

2012-01-01